{"schema_version":"secwatch.filing_event.v1","accession":"0001492298-21-000038","form_type":"8-K","ticker":"SBRA","cik":"0001492298","company_name":"Sabra Health Care REIT, Inc.","filed_at":"2021-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.254418+00:00","generated_at":"2026-06-29T22:31:34.251404+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sabra Q2 net loss $(0.61)/share on $164M Enlivant impairment; CFO to retire Dec 31, 2021","bullets":["Net loss per diluted share $(0.61) includes $(0.76) impairment on Enlivant JV; Normalized FFO $0.41, Normalized AFFO $0.40.","Declared Q3 dividend $0.30/share (75% payout of Normalized AFFO); payable Aug 31, record Aug 17.","Plans to exit Enlivant (49% stake) after impairment; TPG sought management fee changes; JV leverage 20.0x net debt/EBITDA.","CFO Harold Andrews retiring Dec 31, 2021; Michael Costa (EVP Finance & CAO) to become CFO Jan 1, 2022; Andrews to consult 2 years.","Full-year 2021 guidance: Normalized FFO $1.56-$1.58, Normalized AFFO $1.53-$1.55; $111M investments at 8.2% initial cash yield."],"urls":{"canonical":"https://secwatch.observer/filing/0001492298-21-000038","json":"https://secwatch.observer/filing/0001492298-21-000038.json","markdown":"https://secwatch.observer/filing/0001492298-21-000038.md","text":"https://secwatch.observer/filing/0001492298-21-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1492298/000149229821000038/0001492298-21-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1492298/000149229821000038/sbra-20210804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T22:31:34.251404+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7bdd4ed7dc","claim":"Harold Andrews retired as Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary at Sabra Health Care REIT, Inc..","evidence_excerpt":"Harold Andrews, the Company’s Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary, has decided to retire from Sabra, effective December 31, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1492298/000149229821000038/0001492298-21-000038-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary"}],"fact_type":"executive_change"},{"claim_id":"7d30666d79","claim":"Michael Costa was appointed as Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary at Sabra Health Care REIT, Inc..","evidence_excerpt":"Michael Costa, Sabra’s Executive Vice President – Finance and Chief Accounting Officer, is expected to assume each of these positions effective January 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1492298/000149229821000038/0001492298-21-000038-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, Chief Financial Officer (Principal Financial Officer) and Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}